author-photo

Lily Zhang

Fred Hutchinson Cancer Research Center

13

Papers

190

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.

2021 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Pharmacokinetics and predicted neutralization coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

2019 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (28)
Pharmacokinetics Simulations for Studying Correlates of Prevention Efficacy of Passive HIV-1 Antibody Prophylaxis in the Antibody Mediated Prevention (AMP) Study

2018 arXiv: Quantitative Methods
Show All
- Source
- Cite
- Save
Citations (1)
Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults

2017 mAbs
Show All
- Source
- Cite
- Save
Citations (35)
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

2017 Statistical Communications in Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (69)
A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.

2016 Vaccine
Show All
- Source
- Cite
- Save
Citations (6)
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (14)
Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study.

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (15)